It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Hepatic metabolic stability is a key pharmacokinetic parameter in drug discovery. Metabolic stability is usually assessed in microsomal fractions and only the best compounds progress in the drug discovery process. A high-throughput single time point substrate depletion assay in rat liver microsomes (RLM) is employed at the National Center for Advancing Translational Sciences. Between 2012 and 2020, RLM stability data was generated for ~ 24,000 compounds from more than 250 projects that cover a wide range of pharmacological targets and cellular pathways. Although a crucial endpoint, little or no data exists in the public domain. In this study, computational models were developed for predicting RLM stability using different machine learning methods. In addition, a retrospective time-split validation was performed, and local models were built for projects that performed poorly with global models. Further analysis revealed inherent medicinal chemistry knowledge potentially useful to chemists in the pursuit of synthesizing metabolically stable compounds. In addition, we deposited experimental data for ~ 2500 compounds in the PubChem bioassay database (AID: 1508591). The global prediction models are made publicly accessible (https://opendata.ncats.nih.gov/adme). This is to the best of our knowledge, the first publicly available RLM prediction model built using high-quality data generated at a single laboratory.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 National Center for Advancing Translational Sciences (NCATS), Rockville, USA (GRID:grid.429651.d) (ISNI:0000 0004 3497 6087)
2 National Center for Advancing Translational Sciences (NCATS), Rockville, USA (GRID:grid.429651.d) (ISNI:0000 0004 3497 6087); NY State Public Health, Long Island City, USA (GRID:grid.429651.d)
3 National Center for Advancing Translational Sciences (NCATS), Rockville, USA (GRID:grid.429651.d) (ISNI:0000 0004 3497 6087); Virginia Commonwealth University, School of Medicine, Richmond, USA (GRID:grid.224260.0) (ISNI:0000 0004 0458 8737)
4 National Center for Advancing Translational Sciences (NCATS), Rockville, USA (GRID:grid.429651.d) (ISNI:0000 0004 3497 6087); Icahn School of Medicine at Mount Sinai, The Graduate School of Biomedical Sciences, New York, USA (GRID:grid.59734.3c) (ISNI:0000 0001 0670 2351)